propranolol has been researched along with thromboxane a2 in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (48.15) | 18.7374 |
1990's | 11 (40.74) | 18.2507 |
2000's | 2 (7.41) | 29.6817 |
2010's | 1 (3.70) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jancinová, V; Nosál, R; Petríková, M | 1 |
Ishii, A; Karasawa, A; Kawakage, M; Kubo, K; Miki, I; Shirakura, S; Takeda, M | 1 |
Braquet, P; Chabrier, PE; Mencia-Huerta, JM; Pons, F; Touvay, C; Vilain, B | 1 |
Barát, E; Debreczeni, LA; Huszár, E; Vértes, K | 1 |
Calder, AA; Forbes, CD; Greer, IA; McLaren, M; Walker, JJ | 2 |
Viinikka, L; Ylikorkala, O | 1 |
Chung, KF; Evans, TW; Graf, PD; Nadel, JA | 1 |
Corrigan, JJ; Fenster, PE; Ring, ME | 1 |
Albani, F; Cominelli, F; Dabizzi, P; Di Donato, M; Gentilini, P; La Villa, G; Laffi, G; Meacci, E | 1 |
Block, HU; Förster, W; Heinroth, I; Pönicke, K | 1 |
Mehta, J; Mehta, P | 1 |
Förster, W; Höhler, H; Lorenz, S; Taube, C | 1 |
Mehta, J; Mehta, P; Ostrowski, N | 1 |
Mehta, JL | 1 |
Frishman, WH | 1 |
Bund, SJ; Heagerty, AM; Oldham, AA | 1 |
Barman, SA | 1 |
Fujimura, M; Matsuda, T; Mizuhashi, K; Saito, M; Songür, N; Xiu, QY | 1 |
Kabeyama, A; Nishio, A; Obi, T | 1 |
Iizuka, Y; Itoh, K; Mukaiyama, O; Satoh, Y; Terada, A; Yamaguchi, T | 1 |
Goto, S; Inagaki, N; Koda, A; Nagai, H | 1 |
MacAulay, L; MacDonald, A; McLean, M; Shaw, AM | 1 |
Abo, M; Fujimura, M; Hashimoto, T; Ishiura, Y; Kamio, Y; Matsuda, T; Myou, S | 1 |
Amemiya, T; Fujimura, M; Ishiura, Y; Liu, Q; Matsuda, T; Myou, S; Nobata, K; Yamamori, C | 1 |
Fujino, T; Hara, A; Iijima, T; Iwasaki, H; Karibe, H; Kuriyama, S; Narumiya, S; Okada, Y; Ono, K; Takahata, O; Takayama, K; Taniguchi, T; Ushikubi, F; Yamada, T; Yuhki, K | 1 |
Apopa, PL; Bala, M; Boutaud, O; Hamm, HE; Holinstat, M; Oates, JA; Vesci, J | 1 |
1 review(s) available for propranolol and thromboxane a2
Article | Year |
---|---|
Antiplatelet therapy in coronary heart disease.
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Epinephrine; Epoprostenol; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Propranolol; Thromboxane A2 | 1982 |
2 trial(s) available for propranolol and thromboxane a2
Article | Year |
---|---|
Antiplatelet effects of oral diltiazem, propranolol, and their combination.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Diltiazem; Drug Interactions; Epinephrine; Humans; Male; Platelet Aggregation Inhibitors; Propranolol; Thromboxane A2 | 1987 |
Effect of leukotriene and thromboxane antagonist on propranolol-induced bronchoconstriction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Asthma; Benzoquinones; Bronchoconstriction; Chromones; Double-Blind Method; Female; Forced Expiratory Volume; Heptanoic Acids; Humans; Leukotriene Antagonists; Male; Middle Aged; Propranolol; Thromboxane A2; Vital Capacity | 1999 |
24 other study(ies) available for propranolol and thromboxane a2
Article | Year |
---|---|
On the relationship between the inhibition of thrombin stimulated aggregation and thromboxane formation in isolated platelets treated with beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arachidonic Acid; Atenolol; Blood Platelets; Male; Membrane Fluidity; Metipranolol; Oxprenolol; Platelet Aggregation Inhibitors; Practolol; Propranolol; Rats; Rats, Wistar; Thrombin; Thromboxane A2 | 1992 |
Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs.
Topics: Animals; Arrhythmias, Cardiac; Benzimidazoles; Benzoxepins; Collagen; Coronary Disease; Cyclooxygenase Inhibitors; Electrocardiography; Guinea Pigs; Heart Arrest; Male; Nifedipine; Phenylacetates; Propranolol; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Ticlopidine | 1991 |
Bronchopulmonary and vascular effect of endothelin in the guinea-pig.
Topics: Animals; Blood Cell Count; Blood Pressure; Bronchi; Dose-Response Relationship, Drug; Endothelins; Guinea Pigs; Hemodynamics; In Vitro Techniques; Leukocyte Count; Lung; Male; Muscle, Smooth; Muscle, Smooth, Vascular; Peptides; Platelet Count; Propranolol; Pulmonary Circulation; Respiration; Thromboxane A2; Thromboxane B2 | 1990 |
Effects of propranolol, nalorphine and haloperidol on the breathing and on the metabolism of PGI2 and TXA2 of normotensive and spontaneously hypertensive rats.
Topics: Animals; Epoprostenol; Haloperidol; Hypertension; Inspiratory Capacity; Nalorphine; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Respiration; Respiratory Function Tests; Thromboxane A2 | 1989 |
Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Epoprostenol; Humans; Labetalol; Pindolol; Propranolol; Thromboxane A2; Thromboxane B2 | 1985 |
A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
Topics: Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Labetalol; Pindolol; Platelet Aggregation; Prazosin; Propranolol; Thromboxane A2; Thromboxane B2 | 1985 |
Beta blockers inhibit fetal thromboxane A2 production in vitro.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Platelets; Female; Fetal Blood; Humans; Infant, Newborn; Kinetics; Labetalol; Metoprolol; Pregnancy; Propranolol; Thromboxane A2 | 1988 |
Modulation of cholinergic neurotransmission in canine airways by thromboxane mimetic U46619.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Bronchi; Dogs; Electric Stimulation; In Vitro Techniques; Indomethacin; Methacholine Compounds; Muscle Contraction; Parasympathetic Nervous System; Propranolol; Prostaglandin Endoperoxides, Synthetic; Synaptic Transmission; Thromboxane A2 | 1985 |
Systemic haemodynamics, renal and platelet function during chronic propranolol administration in patients with compensated cirrhosis.
Topics: Adult; Blood Platelets; Dinoprostone; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Platelet Aggregation; Propranolol; Prostaglandins E; Renin-Angiotensin System; Thromboxane A2; Thromboxane B2 | 1987 |
Influence of propranolol, pindolol, practolol and talinolol on arachidonic acid (AA)- and U-46619-induced aggregation and on AA-induced thromboxane A2 formation in platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-Antagonists; Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Dose-Response Relationship, Drug; Kinetics; Pindolol; Platelet Aggregation; Practolol; Propanolamines; Propranolol; Prostaglandin Endoperoxides, Synthetic; Rabbits; Thromboxane A2; Thromboxanes | 1983 |
Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease.
Topics: Adult; Arachidonic Acids; beta-Thromboglobulin; Blood Platelets; Coronary Disease; Depression, Chemical; Humans; Middle Aged; Propranolol; Prostaglandins; Thrombin; Thromboxane A2; Thromboxane B2 | 1982 |
The role of TXA2 in hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Clonidine; Dihydralazine; Hypertension; Kidney Medulla; Myocardium; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Thromboxane A2; Thromboxanes; Trapidil | 1984 |
Influence of propranolol and 4-hydroxypropranolol on platelet aggregation and thromboxane A2 generation.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acids; Cell Membrane; Dose-Response Relationship, Drug; Epinephrine; Humans; In Vitro Techniques; Platelet Aggregation; Propranolol; Thromboxane A2; Thromboxanes | 1983 |
Platelets and coronary heart disease: therapy update.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Hemostasis; Humans; Propranolol; Prostaglandin Antagonists; Risk; Sulfinpyrazone; Thromboxane A2 | 1982 |
Influence of arterial diameter on vasomotor responses in the porcine coronary vasculature.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Arteries; Bradykinin; Coronary Circulation; Female; In Vitro Techniques; Male; Norepinephrine; Propranolol; Prostaglandin Endoperoxides, Synthetic; Substance P; Swine; Swine, Miniature; Thromboxane A2; Vasomotor System | 1994 |
Effect of catecholamines on pulmonary circulation at elevated vascular tone.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Catecholamines; Dogs; Female; Lung; Male; Perfusion; Prazosin; Propranolol; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Receptors, Adrenergic; Thromboxane A2; Vascular Resistance; Vasoconstrictor Agents; Yohimbine | 1995 |
Involvement of thromboxane A2 in propranolol-induced bronchoconstriction after allergic bronchoconstriction in guinea pigs.
Topics: Administration, Inhalation; Analysis of Variance; Animals; Asthma; Bridged Bicyclo Compounds; Bronchial Provocation Tests; Constriction, Pathologic; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Guinea Pigs; Hypersensitivity; Inflammation; Injections, Intravenous; Male; Methacholine Chloride; Premedication; Propranolol; Receptors, Prostaglandin; Thromboxane A2; Time Factors | 1994 |
Participation of alpha 1- and beta 1-adrenoceptors in norepinephrine-induced contraction and relaxation of isolated equine coronary artery in vitro.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Animals; Atenolol; Butoxamine; Coronary Vessels; Endothelium, Vascular; Female; Horses; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Phentolamine; Propranolol; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-1; Thromboxane A2; Yohimbine | 1994 |
Effects of CS-518, a thromboxane synthase inhibitor, on the asthmatic response.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Chlorpheniramine; Disease Models, Animal; Guinea Pigs; Indomethacin; Male; Methacrylates; Ovalbumin; Propranolol; Prostaglandin Endoperoxides, Synthetic; SRS-A; Thiophenes; Thromboxane A2; Thromboxane-A Synthase; Vasoconstrictor Agents | 1993 |
Pharmacological model for airway hypersensitivity produced by propranolol and reserpine in guinea pigs.
Topics: Acetylcholine; Animals; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Capillary Permeability; Drug Synergism; Guinea Pigs; Ketotifen; Leukocyte Count; Leukotriene Antagonists; Male; Models, Biological; Propranolol; Reserpine; Respiratory Hypersensitivity; Theophylline; Thromboxane A2 | 1993 |
Effects of propranolol and L-NAME on beta-adrenoceptor-mediated relaxation in rat carotid artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-Agonists; Animals; Carotid Artery, Common; Dose-Response Relationship, Drug; Drug Interactions; Ethanolamines; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Phenylacetates; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Thromboxane A2; Vasoconstrictor Agents | 1999 |
Effect of thromboxane synthase inhibitor, CS-518, on propranolol-induced bronchoconstriction in guinea pigs.
Topics: Adrenergic beta-Antagonists; Animals; Bronchoconstriction; Enzyme Inhibitors; Guinea Pigs; Immunization, Passive; Male; Methacholine Chloride; Muscarinic Agonists; Propranolol; Respiration, Artificial; Thiophenes; Thromboxane A2; Thromboxane-A Synthase | 2000 |
Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia.
Topics: Animals; Blood Pressure; Dinoprost; Electrocardiography; Heart Atria; Heart Rate; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Propranolol; Receptors, Prostaglandin; Receptors, Thromboxane A2, Prostaglandin H2; Tachycardia; Thromboxane A2 | 2005 |
Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis.
Topics: 1-Butanol; 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonate 12-Lipoxygenase; Arachidonic Acid; Blood Platelets; Calcium; Chromones; Cyclooxygenase 1; Cytosol; Eicosanoids; Enzyme Inhibitors; Group IV Phospholipases A2; Humans; In Vitro Techniques; Morpholines; p38 Mitogen-Activated Protein Kinases; Propranolol; Protein Kinase C; Receptors, Proteinase-Activated; Signal Transduction; Thromboxane A2 | 2011 |